Creighton University School of Medicine, Division of Pulmonary and Critical Care, Omaha, Nebraska.
Creighton University School of Medicine, Department of Clinical Research, Omaha, Nebraska.
Respir Care. 2023 Jan;68(1):52-59. doi: 10.4187/respcare.10080. Epub 2022 Jun 15.
The evolution of compliance and driving pressure in ARDS and the effects of time spent on noninvasive respiratory support prior to intubation have not been well studied. We conducted this study to assess the effect of the duration of noninvasive respiratory support prior to intubation (ie, noninvasive ventilation [NIV], high-flow nasal cannula [HFNC], or a combination of NIV and HFNC) on static compliance and driving pressure and retrospectively describe its trajectory over time for COVID-19 and non-COVID-19 ARDS while on mechanical ventilation.
This is a retrospective analysis of prospectively collected data from one university-affiliated academic medical center, one rural magnet hospital, and 3 suburban community facilities. A total of 589 subjects were included: 55 COVID-19 positive, 137 culture positive, and 397 culture-negative subjects. Static compliance and driving pressure were calculated at each 8-h subject-ventilator assessment.
Days of pre-intubation noninvasive respiratory support were associated with worse compliance and driving pressure but did not moderate any trajectory. COVID-19-positive subjects showed non-statistically significant worsening compliance by 0.08 units per subject-ventilator assessment ( = .24), whereas COVID-19-negative subjects who were either culture positive or negative showed statistically significant improvement (0.12 and 0.18, respectively; both < .05); a statistically similar but inverse pattern was observed for driving pressure.
In contrast to non-COVID-19 ARDS, COVID-19 ARDS was associated with a more ominous trajectory with no improvement in static compliance or driving pressures. Though there was no association between days of pre-intubation noninvasive respiratory support and mortality, its use was associated with worse overall compliance and driving pressure.
ARDS 患者顺应性和驱动压的演变以及插管前接受无创性呼吸支持的时间长短的影响尚未得到很好的研究。我们进行这项研究是为了评估插管前无创性呼吸支持(即无创通气[NIV]、高流量鼻导管[HFNC]或两者联合)的持续时间对静态顺应性和驱动压的影响,并回顾性描述 COVID-19 和非 COVID-19 ARDS 患者在机械通气时其随时间的变化轨迹。
这是对一家大学附属学术医疗中心、一家农村磁铁医院和 3 家郊区社区设施前瞻性收集数据的回顾性分析。共纳入 589 例患者:55 例 COVID-19 阳性、137 例培养阳性和 397 例培养阴性。在每次 8 小时的受试者-呼吸机评估中计算静态顺应性和驱动压。
插管前无创性呼吸支持的天数与顺应性和驱动压变差相关,但没有调节任何轨迹。COVID-19 阳性患者的顺应性每例呼吸机评估增加 0.08 单位,但无统计学意义( =.24),而 COVID-19 阴性患者(培养阳性或阴性)的顺应性均有统计学显著改善(分别为 0.12 和 0.18;均<.05);驱动压也观察到类似但相反的模式。
与非 COVID-19 ARDS 相比,COVID-19 ARDS 与更险恶的轨迹相关,静态顺应性或驱动压无改善。虽然插管前无创性呼吸支持的天数与死亡率之间没有关联,但它的使用与整体顺应性和驱动压较差有关。